GT Biopharma Company Update [A Must See]
TAMPA, Florida, June 10, 2019 /PRNewswire/ — GT Biopharma, Inc. (GTBP) (GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company’s proprietary NK cell engager (TriKE) platform and Multi-Target Directed Bispecific Drug Conjugate (MTBDC) platform, today provided an update of the company’s drug development programs.
Click Here To Read Full Press Release
U.S. Spends Nearly $800B On Food Delivery – Here Are Some Stocks To Watch
The industry is growing at a breakneck pace as more and more American prefer to order food with a few taps on their phone, but the competition has grown intense between the major players in the industry.
Click Here For Full Article
Defense & Weapons Detection Technology Trigger New Attention From Investors
There are very few industries which continue to grow at such a pace as the Defense and weapons detection technology industries. Due to the staggering spending that the United States government embarks on every year, it is probably the most stable industry in existence.
Click Here To Read More
